Abstract
Ultrasound in pregnancy has become standard of care, resulting in an increased number of antenatally diagnosed fetal anomalies. It isimportant to have a consistent approach to the management of these abnormalities. This may include offering termination of pregnancy,standard care or non-aggressive/palliative care. A categorisation of anomalies and management options is proposed to assist with thesedecisions, underpinned by an ethical framework.
Publisher
South African Medical Association NPC
Subject
Obstetrics and Gynecology
Reference26 articles.
1. Oladapo OT. Amniocentesis and chorionic villus sampling for prenatal diagnosis: RHL commentary (last revised 1 April 2009). The WHO Reproductive Health Library. Geneva: World Health Organization. https://srhr.org/rhl/article/amniocentesis-and-chorionic-villus-sampling- for-prenatal-diagnosis (accessed 1 November 2022).
2. National Institute for Health and Care Excellence (NICE). Antenatal care: NICE guideline (NG201). 19 August 2021. www.nice.org.uk/guidance/ng201 (accessed 20 March 2022).
3. Nicolaides KH. Screening for fetal aneuploidies at 11 to 13 weeks. Prenat Diagn 2011;31(1):7-15.
4. https://doi.org/10.1002/pd.2637
5. Evans MI, O’Brien JE, Dvorin E, Harrison H, Bui TH. Second-trimester biochemical screening. Clin Perinatol 2001;28(2):289-301. https://doi.org/10.1016/s0095-5108(05)70084-1